PDE inhibitors: a new approach to treat metabolic syndrome?
- 作者Claire Lugnier
- 卷第11卷
- 期第6期
- 印刷ISSN1471-4892
- 文件大小395.03KB
- 发表时间2011
- DOI10.1016/j.coph.2011.09.012
Phosphodiesterase Methods and Protocols Volume 307 ||Lugnier, Claire · 2005
Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide MotifsKeravis, Therese; Lugnier, Claire · Current Pharmaceutical Design · 2010
G-proteins from cultured bovine aortic endothelial cellsJosé Gil-Longo; Claire Lugnier · 1992
Biflavones of <i>Decussocarpus rospigliosii</i> as Phosphodiesterases InhibitorsChaabi, Mehdi; Antheaume, Cyril; Weniger, Bernard; Justiniano, Hélène; Lugnier, Claire; Lobstein, Annelise · Planta Medica · 2007
Interactions of calmodulin antagonists with calcium antagonists binding sitesPaul Schaeffer; Claire Lugnier; Jean-Claude Stoclet · 1991
Variations in endogenous phosphodiesterase activator content of rat aortaClaire Lugnier; Brigitte Ilien; Jean-Claude Stoclet · 1978
Phosphodiesterase Methods and Protocols Volume 307 || Crystallization of Cyclic Nucleotide PhosphodiesterasesLugnier, Claire · 2005